Skip to main content
logo
Tanvex BioPharma, Inc. (TPE:6541)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
51.00
+0.30 (0.59%)
Sep 10, 2025, 1:30 PM CST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Biopharmaceuticals
34.68M
Log In
Log In
Log In
Log In
Biopharmaceuticals Growth
-43.53%
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
United States
34.68M
Log In
Log In
Log In
Log In
United States Growth
349.84%
Log In
Log In
Log In
Log In
Taiwan
-
Log In
Log In
Log In
Log In
Taiwan Growth
-
Log In
Log In
Log In
Log In